Publicacións nas que colabora con Almudena Gil Rodríguez (11)

2025

  1. A Lack of Complete Linkage Disequilibrium Between c.1236G>A and c.1129-5923C>G HapB3 Variants of DPYD: A Call to Revise European Pharmacogenetic Guidelines

    International Journal of Molecular Sciences, Vol. 26, Núm. 17

  2. Balance of care activity after EMA recommendation for DPYD gene testing in Galicia

    Frontiers in Pharmacology, Vol. 16

  3. Differences in DPYD Population Frequencies Observed in Galicians Compared to Europeans and Spanish from PhotoDPYD Study

    Pharmaceuticals, Vol. 18, Núm. 4

  4. Exploring the sensory profile and pharmacogenetic biomarkers in child and youth ADHD patients undergoing methylphenidate (MPH) treatment: a systematic review conducted in European studies

    Journal of Psychiatric Research, Vol. 190, pp. 512-521

  5. Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients

    Biomedicines, Vol. 13, Núm. 3

  6. The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review

    Pharmaceuticals, Vol. 18, Núm. 5

2024

  1. Farmacogenética

    Medicina interna (Elsevier España), pp. 1284-1291

  2. Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives

    Drug Metabolism and Personalized Therapy, Vol. 39, Núm. 4, pp. 183-199

  3. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling

    Psychiatry Research, Vol. 333

2023

  1. Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report

    Frontiers in Pharmacology, Vol. 14

  2. Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration

    Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34